# Quality Assurance Report

## Identity

| Field | Value |
|---|---|
| QA Report ID | QA-PP-0157 |
| Population Package | PP-0157 |
| Title | Cascade Testing in Hereditary Gastric Cancer |
| Version | 1.0.0 |
| Status | PASS |

---

# 1. Content QA

| Criterion | Result |
|---|---|
| Single clinical question | PASS |
| Atomic family-level scope | PASS |
| Familial pathogenic variant starting point | PASS |
| At-risk relatives defined | PASS |
| Proband role included | PASS |
| Family notification included | PASS |
| Familial-variant testing included | PASS |
| Positive result pathway included | PASS |
| Negative result pathway included | PASS |
| Multigenerational cascade included | PASS |
| Uptake barriers included | PASS |
| Information comprehension included | PASS |
| Counseling handoff included | PASS |
| Privacy/ethical context included | PASS |
| Downstream management handoff included | PASS |

---

# 2. Clinical QA

| Criterion | Result |
|---|---|
| Cascade testing distinguished from initial genetic testing | PASS |
| Cascade testing distinguished from genetic counseling | PASS |
| Familial pathogenic variant established as starting point | PASS |
| Biological-relative pathway correctly represented | PASS |
| Positive carrier result correctly routed downstream | PASS |
| Negative familial-variant result correctly handled | PASS |
| Negative result not equated with zero cancer risk | PASS |
| Multigenerational cascade correctly represented | PASS |
| No unsupported universal HDGC uptake rate | PASS |
| No unsupported universal cascade protocol | PASS |
| No individualized testing recommendation | PASS |
| No individualized risk calculation | PASS |
| No gene-specific variant interpretation | PASS |

---

# 3. Evidence QA

| Criterion | Result |
|---|---|
| NCI Cancer Genetics Risk Assessment and Counseling prioritized | PASS |
| NCI cascade-testing section used directly | PASS |
| Gastric-genetics source used for disease context | PASS |
| HDGC PDQ used for hereditary-gastric context | PASS |
| Evidence hierarchy defined | PASS |
| Evidence-to-content matrix completed | PASS |
| Evidence limitations documented | PASS |
| HBOC/Lynch uptake data not misrepresented as HDGC data | PASS |
| Source traceability included | PASS |

---

# 4. Educational QA

| Criterion | Result |
|---|---|
| Plain language | PASS |
| Family-centered explanation | PASS |
| Cascade concept easy to follow | PASS |
| Positive/negative distinction clear | PASS |
| Counseling/testing distinction clear | PASS |
| Family communication understandable | PASS |
| Barriers explained without blame | PASS |
| Uncertainty preserved | PASS |
| No unnecessary alarm | PASS |

---

# 5. Governance QA

| Criterion | Result |
|---|---|
| CKO completed | PASS |
| Knowledge Passport completed | PASS |
| Primary Evidence Package completed | PASS |
| QA Report completed | PASS |
| Gold specification followed | PASS |
| Locked Decision Batch implemented | PASS |
| Scope not reopened | PASS |
| Boundary explicitly defined | PASS |
| Adjacent PP overlap checked | PASS |
| Knowledge Graph documented | PASS |
| Four-artifact package complete | PASS |

---

# 6. Boundary / Overlap QA

## PP-0156 — Genetic Counseling

Owns:

> counseling, informed decision-making, psychosocial support, pretest/posttest counseling.

PP-0157 uses counseling only as the entry/support layer for relatives.

**Result: PASS**

---

## PP-0154 — Hereditary Gastric Cancer Risk Assessment

Owns:

> formal hereditary-risk assessment.

PP-0157 starts after the familial pathogenic variant has been identified.

**Result: PASS**

---

## PP-0152 — HDGC Genetic Testing Criteria

Owns:

> exact HDGC testing criteria.

PP-0157 does not reproduce them.

**Result: PASS**

---

## PP-0016 — Genetic Testing

Owns:

> general testing methodology and testing concepts.

PP-0157 focuses on the family pathway after a familial variant is known.

**Result: PASS**

---

## PP-0150 / PP-0151

Own:

> CDH1 / CTNNA1-specific knowledge.

PP-0157 does not interpret the variants.

**Result: PASS**

---

## PP-0153

Owns:

> HDGC-like families and unresolved hereditary phenotype.

PP-0157 only acknowledges downstream routing when a familial variant is not found or the phenotype remains unresolved.

**Result: PASS**

---

## PP-0158 / PP-0159

Own:

> risk-reducing gastrectomy / HDGC endoscopic surveillance.

PP-0157 ends at the downstream management handoff.

**Result: PASS**

---

# 7. Clinical Safety QA

| Safety Item | Result |
|---|---|
| No automatic testing recommendation to an individual | PASS |
| No coercive family-disclosure instruction | PASS |
| No claim that all relatives must test | PASS |
| No claim that negative result means zero cancer risk | PASS |
| No individual variant interpretation | PASS |
| No individualized management recommendation | PASS |
| No surgery recommendation | PASS |
| No surveillance recommendation | PASS |
| Legal/duty-to-warn claims appropriately jurisdiction-limited | PASS |
| Emotional/family barriers presented nonjudgmentally | PASS |

---

# 8. Knowledge Graph QA

```text
PP-0155
Family history
        ↓
PP-0154
Hereditary risk assessment
        ↓
PP-0156
Genetic counseling
        ↓
Familial pathogenic variant identified
        ↓
PP-0157
Cascade testing
        ↓
At-risk biological relatives
        ↓
Familial-variant testing
        ↓
┌──────────────────────┐
│ Positive             │
│ → carrier            │
│ → next cascade node  │
└──────────────────────┘
        │
        ▼
Downstream hereditary management
        │
        ├── PP-0149
        ├── PP-0158
        └── PP-0159
```

No architecture conflict identified.

**Result: PASS**

---

# 9. Gold Artifact QA

| Artifact | Present | Status |
|---|---|---|
| 01_CKO.md | Yes | PASS |
| 02_KNOWLEDGE_PASSPORT.md | Yes | PASS |
| 03_PRIMARY_EVIDENCE_PACKAGE.md | Yes | PASS |
| 04_QA_REPORT.md | Yes | PASS |

---

# 10. Final QA Decision

# PASS

PP-0157 satisfies the locked Gold Population Package requirements.

The package establishes a distinct family-level function:

> **PP-0157 = CASCADE TESTING PATHWAY**

It does not duplicate:

- PP-0154 risk assessment;
- PP-0156 genetic counseling;
- PP-0016 genetic testing;
- PP-0152 HDGC criteria;
- PP-0150/0151 gene interpretation;
- PP-0153 HDGC-like state;
- PP-0158 surgery;
- PP-0159 surveillance.

---

# Final Status

**GOLD — PASS — READY FOR INTEGRATION**
